Sagittarius Life Science Corp. announced earnings results for the third quarter ended September 30, 2020. For the third quarter, the company announced sales was TWD 128.910 million compared to TWD 114.440 million a year ago. Operating loss was TWD 20.253 million compared to TWD 28.996 million a year ago. Net loss was TWD 20.873 million compared to TWD 27.934 million a year ago. Basic loss per share was TWD 0.64 compared to TWD 0.85 a year ago. For the nine months, sales was TWD 413.022 million compared to TWD 331.049 million a year ago. Operating loss was TWD 57.744 million compared to TWD 79.909 million a year ago. Net loss was TWD 54.765 million compared to TWD 75.122 million a year ago. Basic loss per share was TWD 1.68 compared to TWD 2.29 a year ago.